GKGurvinder Kaur

Gurvinder Kaur

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Gurvinder Kaur has a total of 148 co-authors. Here are the top co-authors by number of shared publications:

  • Anubha Gupta

    Department of Electronics and Communication Engineering, IIIT-Delhi, New Delhi, India

    2 shared publications
  • Ritu Gupta

    Laboratory Oncology Unit, Dr. B. R. Ambedkar Institute Rotary Cancer Hospital, All India Institute of Medical Sciences, New Delhi, 110029, India

    2 shared publications
  • A Jeong

    Boschstraße 12, 69469

    1 shared publication
  • A. Wanchu

    Department of Internal Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh, India

    1 shared publication
  • Ajay Gogia

    Department of Medical Oncology, Dr. B.R.A.IRCH, All India Institute of Medical Sciences, New Delhi, India

    1 shared publication
  • Akanksha Farswan

    SBILab, Department of Electronics and Communication Engineering, IIIT, Delhi

    1 shared publication

Latest Publications

  • Open Access

    Graphisches Inhaltsverzeichnis: Angew. Chem. 21/2023

    by Anna Hartmann, Marion Schulz, B. Chakraborty, Christopher J. Luscombe, Liang Zhang, Nicolás Montesdeoca, Johannes Karges, Hong Xiao, Gajanand Sharma, Tida Ge, et al.

  • Killer cell immunoglobulin‐like receptor three domains long cytoplasmic tail 1 gene *007 may modulate disease progression of human immunodeficiency virus‐1 infection in the Japanese population

    by Taeko K. Naruse, Makiko Konishi‐Takemura, Risa Yanagida, Gaurav Sharma, Madhu Vajpayee, Hiroshi Terunuma, Narinder K. Mehra, Gurvinder Kaur, Akinori Kimura

    One of the KIR allele, KIR3DL1*007, was associated with the progression to acquired immunodeficiency syndrome and not with the susceptibility to HIV-1 infection in the Japanese and Indian populations, implying that KIR3DL1*007-positive NK cells might eliminate HIV-infected cells less effectively than NK cells bearing the other KIR3DL1 alleles or KIR3DS1 alleles.

  • Open Access

    Correlation of changes in subclonal architecture with progression in the MMRF CoMMpass study

    by Gurvinder Kaur, Lingaraja Jena, Ritu Gupta, Akanksha Farswan, Anubha Gupta, K Sriram


  • Open Access

    Formative Assessments Predict Performance and Promote a Positive Learning Environment

    by Brandt Schneider, Gurvinder Kaur, Keith Bishop, Megh Gore, Katie Higgins, Bridget Vories, Simon Williams, Vaughan Lee

    At Texas Tech University Health Sciences Center School of Medicine, our curriculum begins with a rigorous and fast‐paced Clinically Oriented Anatomy course. Over the past four years, we have increased and improved the use of formative quizzes and exams to promote higher learning and performance outcomes, clarify examination expectations, and reduce student stress. Prior to starting our curriculum students are offered the opportunity to take a 25 question comprehensive formative pre‐test that previews examination content and USMLE vignette style questions. In the past year, we found that 93% of the incoming class utilized this voluntary resource. An average score of 23% on this pre‐test is consistent with a lack of familiarity of incoming students with human anatomy. To evaluate the effectiveness of our curriculum to bridge this informational gap, we provide students with two formative assessments (practice practical and practice written exam) prior to each summative exam. Computer based laboratory practice exams use digital images of prosected cadavers while didactic exams encompass a range of first, second and third order questions. Post‐assessment question/answer rationales provide students with immediate feedback to help identify areas of strength and weakness. Using this formative assessment approach, we have investigated the ability of formative assessments to predict exam performance and identify “at risk” students early in the course (i.e. after taking the first formative practice exam). Analysis of formative assessment data revealed a strong correlation with graded exam performance (p values ranging from 0.01–0.001 and r values from 0.44–0.70) . Furthermore, overall graded summative exams correlate strongly with NBME performance (p = 0.001 and r = 0.92). Indicative of a successful educational experience, students scored an average of 233% higher on the repeat post‐course formative exam . Furthermore, the student’s perception of these formative assessments is very favorable and increases each year. In the past year, we had significantly fewer “at risk” students, and NBME performance was a record high. Thus, we find that formative assessments improve the educational experience, boost exam performance, and reduce student stress. Support or Funding Information: (Sponsored by the Department of Medical Education at the TTUHSC SOM.)This study is approved by TTUHSC‐QIRB (approval#17008)


  • Open Access

    RNA-Seq profiling of deregulated miRs in CLL and their impact on clinical outcome

    by Gurvinder Kaur, Vivek Ruhela, Lata Rani, Anubha Gupta, Krishnamachari Sriram, Ajay Gogia, Atul Sharma, Lalit Kumar, Ritu Gupta

    Abnormal expression patterns of regulatory small non-coding RNA (sncRNA) molecules such as microRNAs (miRs), piwi-interacting RNAs (piRNAs), and small nucleolar RNAs (snoRNAs) play an important role in the development and progression of cancer. Identification of clinically relevant sncRNA signatures could, therefore, be of tremendous translational value. In the present study, genome-wide small RNA sequencing identified a unique pattern of differential regulation of eight miRs in Chronic Lymphocytic Leukemia (CLL). Among these, three were up-regulated (miR-1295a, miR-155, miR-4524a) and five were down-regulated (miR-30a, miR-423, miR-486*, let-7e, and miR-744) in CLL. Altered expression of all these eight differentially expressed miRs (DEMs) was validated by RQ-PCR. Besides, seven novel sequences identified to have elevated expression levels in CLL turned out to be transfer RNA (tRNA)/piRNAs (piRNA-30799, piRNA-36225)/snoRNA (SNORD43) related. Multivariate analysis showed that miR-4524a (HR: 1.916, 95% CI: 1.080–3.4, p value: 0.026) and miR-744 (HR: 0.415, 95% CI: 0.224–0.769, p value: 0.005) were significantly associated with risk and time to first treatment. Further investigations could help establish the scope of integration of these DEM markers into risk stratification designs and prognostication approaches for CLL.


  • Association of cutaneous adverse drug reactions due to antiepileptic drugs with HLA alleles in a North Indian population

    by Kavish Ihtisham, Bhargavi Ramanujam, Shivani Srivastava, Narinder Kumar Mehra, Gurvinder Kaur, Neena Khanna, Satish Jain, Sachin Kumar, Bhavna Kaul, Raghavan Samudrala, et al.


  • Sequence and Phylogenetic Analysis of the Untranslated Promoter Regions for HLA Class I Genes

    by Veron Ramsuran, Pedro G. Hernández-Sanchez, Colm O’huigin, Gaurav Sharma, Niamh Spence, Danillo G. Augusto, Xiaojiang Gao, Christian A García-Sepúlveda, Gurvinder Kaur, Narinder K. Mehra, et al.

    Polymorphisms located within the MHC have been linked to many disease outcomes by mechanisms not yet fully understood in most cases. Variants located within untranslated regions of HLA genes are involved in allele-specific expression and may therefore underlie some of these disease associations. We determined sequences extending nearly 2 kb upstream of the transcription start site for 68 alleles from 57 major lineages of classical HLA class I genes. The nucleotide diversity within this promoter segment roughly follows that seen within the coding regions, with HLA-B showing the highest (∼1.9%), followed by HLA-A (∼1.8%), and HLA-C showing the lowest diversity (∼0.9%). Despite its greater diversity, HLA-B mRNA expression levels determined in 178 European Americans do not vary in an allele- or lineage-specific manner, unlike the differential expression levels of HLA-A or HLA-C reported previously. Close proximity of promoter sequences in phylogenetic trees is roughly reflected by similarity of expression pattern for most HLA-A and -C loci. Although promoter sequence divergence might impact promoter activity, we observed no clear link between the phylogenetic structures as represented by pairwise nucleotide differences in the promoter regions with estimated differences in mRNA expression levels for the classical class I loci. Further, no pair of class I loci showed coordinated expression levels, suggesting that distinct mechanisms across loci determine their expression level under nonstimulated conditions. These data serve as a foundation for more in-depth analysis of the functional consequences of promoter region variation within the classical HLA class I loci.


  • CTLA4+49G allele associates with early onset of type 1 diabetes in North Indians

    by N. Kumar, G. Kaur, U. Kanga, N. K. Mehra, S. C. Neolia, N. Tandon, S. C. Zucman

    Summary: Type 1 diabetes (T1D) is a complex autoimmune disease with strong genetic influence. In this study, we investigated +49A/G SNP (rs 231775) in exon 1 of cytotoxic T‐lymphocyte‐associated antigen 4 (CTLA4) by PCR‐RFLP and its influence as a risk factor for the disease in the North Indian population. This polymorphism at codon 17 results in an amino acid substitution (Thr/Ala) in the leader peptide of the molecule. The study included 232 patients with T1D (age at onset of disease (AOD): 0.5–37 years) and 305 ethnically matched healthy controls. The DNA obtained from these 537 individuals was amplified using a set of specific primers followed by restriction enzyme digestion with Fnu4HI. The +49G allele as well as its homozygous genotype G/G was observed to be significantly higher in patients as compared to the healthy controls {(37.3% vs. 25.6%, P = 4.96E−05, OR = 1.73; 95%CI = 1.33–2.25) (15.52% vs. 6.6%, P = 0.001, OR = 2.62; 95% CI = 1.48–4.63) respectively}. The frequency of G/G genotype was significantly higher in patients with early age at onset of disease (AOD:P = 0.042, OR = 2.26; 95% CI = 1.09–4.67) as well as to that in the healthy controls (21.1% vs. 6.6%, P = 0.00004, OR = 3.8; 95% CI = 2.01–7.2). Further analysis revealed that the median AOD significantly reduced (P = 0.049) from 14 years in patients with A/A genotype to 11 and 10 years in those with A/G and G/G genotypes, respectively. These results suggest that CTLA4+49G allele, particularly in homozygous G/G condition, associates with early onset of T1D.


  • Polymorphism in the CCR5 Gene Promoter and HIV-1 Infection in North Indians

    by Gurvinder Kaur, P. Singh, C.C. Rapthap, N. Kumar, M. Vajpayee, S.K. Sharma, A. Wanchu, N.K. Mehra